Neuropsychiatric sequelae of COVID-19 after vaccination: A gathering storm?

Abstract

Before the widespread availability of SARS-CoV-2 vaccination, large-scale analyses of health records and of primary studies had identified a high frequency of neuropsychiatric symptoms during and after recovery from acute COVID-19 (Taquet et al., 2021, Taquet et al., 2021, Rogers et al., 2021, Badenoch et al., 2022). Vaccination created a new epoch in which deaths and acute critical illness are greatly reduced, but in which SARS-CoV-2 infection continues – in millions of people every week, multiple waves, and novel variants (WHO, 2022). It is therefore increasingly important to know whether vaccines also reduce the longer-term sequelae of COVID-19; discussed here through the lens of our interest in its neuropsychiatric consequences.

Rights

This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.

Cite as

Downloadable citations

Identifiers

DOI

https://doi.org/10.1016/j.bbi.2022.07.166

Repository URI

https://www.research.ed.ac.uk/en/publications/76fcb929-5cc2-41d9-ad44-da0095e256c0